Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression.
Rivalta B, Attardi E, Cifaldi C, Rosti V, Pacillo L, Hajrullaj H, Di Cesare S, Amodio D, Algeri M, Luciani M, Barzaghi F, Finocchi A, Di Matteo G, Aiuti A, Locatelli F, Voso MT, Palumbo G, Cancrini C. Rivalta B, et al. Among authors: voso mt. Br J Haematol. 2024 Jan;204(1):e6-e10. doi: 10.1111/bjh.19150. Epub 2023 Nov 3. Br J Haematol. 2024. PMID: 37921255 No abstract available.
PML/RARA inhibits expression of HSP90 and its target AKT.
Piredda ML, Gaur G, Catalano G, Divona M, Banella C, Travaglini S, Puzzangara MC, Voso MT, Lo-Coco F, Noguera NI. Piredda ML, et al. Among authors: voso mt. Br J Haematol. 2019 Mar;184(6):937-948. doi: 10.1111/bjh.15715. Epub 2018 Dec 9. Br J Haematol. 2019. PMID: 30536958 Free article.
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept.
Travaglini S, Gurnari C, Antonelli S, Marchesi F, De Angelis G, Ottone T, Divona M, Cristiano A, Hajrullaj H, Mengarelli A, Voso MT. Travaglini S, et al. Among authors: voso mt. Br J Haematol. 2023 Oct;203(2):327-330. doi: 10.1111/bjh.18991. Epub 2023 Jul 23. Br J Haematol. 2023. PMID: 37485586 No abstract available.
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways.
Ottone T, Silvestrini G, Piazza R, Travaglini S, Gurnari C, Marchesi F, Nardozza AM, Fabiani E, Attardi E, Guarnera L, Divona M, Ricci P, Irno Consalvo MA, Ienzi S, Arcese R, Biagi A, Fiori L, Novello M, Mauriello A, Venditti A, Anemona L, Voso MT. Ottone T, et al. Among authors: voso mt. Leukemia. 2023 Dec;37(12):2383-2394. doi: 10.1038/s41375-023-02054-0. Epub 2023 Oct 6. Leukemia. 2023. PMID: 37803061
Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution.
Fabiani E, Cristiano A, Hajrullaj H, Falconi G, Leone G, Voso MT. Fabiani E, et al. Among authors: voso mt. Mediterr J Hematol Infect Dis. 2023 Nov 1;15(1):e2023064. doi: 10.4084/MJHID.2023.064. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 38028397 Free PMC article. Review.
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).
Fabiani E, Calabrese C, Niscola P, Balleari E, Molteni A, Finelli C, Falconi G, Fenu S, Fianchi L, Criscuolo M, Salvi F, Lavorgna S, Buccisano F, Maurillo L, Lo Coco F, Cilloni D, Voso MT. Fabiani E, et al. Among authors: voso mt. Br J Haematol. 2019 Jun;185(5):954-957. doi: 10.1111/bjh.15655. Epub 2018 Nov 8. Br J Haematol. 2019. PMID: 30407614 Free article. No abstract available.
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations.
Gurnari C, Lombardi AM, Cosi E, Biagetti G, Buccisano F, Franceschini L, Di Veroli A, Falconi G, Fabiani E, Cantonetti M, Nasso D, Lo-Coco F, Randi ML, Voso MT. Gurnari C, et al. Among authors: voso mt. Br J Haematol. 2019 Aug;186(4):e100-e103. doi: 10.1111/bjh.15931. Epub 2019 Apr 23. Br J Haematol. 2019. PMID: 31016714 Free article. No abstract available.
316 results